|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,530,000,000 |
Market
Cap: |
331.94(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$100.18 - $131.95 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
|
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
MAJOR MARKET |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 330 |
Guru Rank Value : 3.8 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Co.'s segments are: Pharmaceutical, which includes human health pharmaceutical products that consist of therapeutic and preventive agents for the treatment of human disorders, and human health vaccine products that consist of preventive pediatric, adolescent and adult vaccines; and Animal Health, which discovers, develops, manufactures and markets veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
409 |
Total Buy Value |
$0 |
$0 |
$0 |
$44,337 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
8 |
Total Shares Sold |
409,617 |
455,521 |
560,285 |
4,068,540 |
Total Sell Value |
$51,615,837 |
$56,431,566 |
$68,728,071 |
$427,246,334 |
Total People Sold |
8 |
9 |
10 |
12 |
Total Sell Transactions |
9 |
11 |
19 |
48 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Frazier Kenneth C |
Chairman, President & CEO |
|
2012-02-28 |
4 |
A |
$38.38 |
$814,731 |
D/D |
21,228 |
213,748 |
|
- |
|
Graddick Weir Mirian M |
Exe V-P, HR |
|
2012-02-28 |
4 |
A |
$38.38 |
$334,098 |
D/D |
8,705 |
45,873 |
|
- |
|
Deese Willie A |
Exe V-P & Pres. MMD |
|
2012-02-28 |
4 |
A |
$38.38 |
$370,597 |
D/D |
9,656 |
88,410 |
|
- |
|
Kellogg Peter N |
Exe V-P & CFO |
|
2012-02-28 |
4 |
A |
$38.38 |
$501,588 |
D/D |
13,069 |
67,068 |
|
- |
|
Scalet James Christopher |
Exe V-P Global Srvs & CIO |
|
2012-02-28 |
4 |
A |
$38.38 |
$334,251 |
D/D |
8,709 |
63,833 |
|
- |
|
Ambrose Adele D |
Sr.V-P & Chief Comuns Officer |
|
2012-02-28 |
4 |
A |
$38.38 |
$41,105 |
D/D |
1,071 |
4,267 |
|
- |
|
Kuhlik Bruce N |
Exe V-P & Gen Counsel |
|
2012-02-28 |
4 |
A |
$38.38 |
$390,133 |
D/D |
10,165 |
68,316 |
|
- |
|
Schechter Adam H |
EVP & Pres-Global Human Health |
|
2012-02-28 |
4 |
A |
$38.38 |
$352,866 |
D/D |
9,194 |
9,194 |
|
- |
|
Bowles Richard S Iii |
Exe VP&Chief Ethics & ComplOff |
|
2012-02-17 |
4 |
S |
$38.76 |
$1,643,003 |
D/D |
(42,367) |
73,540 |
|
- |
|
Bowles Richard S Iii |
Exe VP&Chief Ethics & ComplOff |
|
2012-02-17 |
4 |
OE |
$21.08 |
$1,268,519 |
D/D |
42,367 |
115,907 |
|
- |
|
Deese Willie A |
Exe V-P & Pres. MMD |
|
2012-02-08 |
4 |
S |
$38.33 |
$1,629,667 |
D/D |
(42,466) |
78,750 |
|
- |
|
Deese Willie A |
Exe V-P & Pres. MMD |
|
2012-02-08 |
4 |
OE |
$23.45 |
$995,828 |
D/D |
42,466 |
121,216 |
|
- |
|
Bowles Richard S Iii |
Exe VP&Chief Ethics & ComplOff |
|
2011-11-11 |
4 |
S |
$35.90 |
$1,077,000 |
D/D |
(30,000) |
76,575 |
|
- |
|
Bowles Richard S Iii |
Exe VP&Chief Ethics & ComplOff |
|
2011-11-11 |
4 |
OE |
$21.08 |
$632,400 |
D/D |
30,000 |
106,575 |
|
- |
|
Weeks Wendell P |
Director |
|
2011-10-04 |
4 |
S |
$31.35 |
$3,135 |
I/I |
(100) |
0 |
|
- |
|
Frazier Kenneth C |
President & CEO |
|
2011-08-15 |
4 |
B |
$31.77 |
$1,016,838 |
D/D |
32,000 |
192,520 |
2.81 |
- |
|
Kellogg Peter N |
Exe V-P & CFO |
|
2011-08-12 |
4 |
B |
$31.77 |
$502,366 |
D/D |
15,800 |
53,999 |
2.74 |
- |
|
Kohan Raul E |
Exe V-P & Pres, Animal Health |
|
2011-05-18 |
4 |
S |
$37.14 |
$2,376,876 |
D/D |
(63,881) |
78,167 |
|
- |
|
Kohan Raul E |
Exe V-P & Pres, Animal Health |
|
2011-05-18 |
4 |
OE |
$19.95 |
$1,274,426 |
D/D |
63,881 |
142,048 |
|
- |
|
Bowles Richard S Iii |
Exe V-P & Chief Compl Officer |
|
2011-05-04 |
4 |
S |
$36.55 |
$1,087,724 |
D/D |
(29,755) |
76,575 |
|
- |
|
Bowles Richard S Iii |
Exe V-P & Chief Compl Officer |
|
2011-05-04 |
4 |
OE |
$22.69 |
$675,141 |
D/D |
29,755 |
106,330 |
|
- |
|
Ambrose Adele D |
Sr.V-P & Chief Comuns Officer |
|
2011-05-01 |
4 |
D |
$35.95 |
$13,086 |
D/D |
(364) |
3,097 |
|
- |
|
Ambrose Adele D |
Sr.V-P & Chief Comuns Officer |
|
2011-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
3,461 |
|
- |
|
Kuhlik Bruce N |
Exe V-P & Gen Counsel |
|
2011-02-28 |
4 |
D |
$32.19 |
$211,327 |
D/D |
(6,565) |
55,749 |
|
- |
|
Kuhlik Bruce N |
Exe V-P & Gen Counsel |
|
2011-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,700 |
62,314 |
|
- |
|
510 Records found
|
|
Page 7 of 21 |
|
|